Pandion Operations, Inc.
11Patents
11Active
11Granted
44Portfolio score
Filing activity: Mar 15, 2018 → Jul 28, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10946068B2 | IL-2 muteins and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US10961310B2 | Targeted immunotolerance | Chemistry; Metallurgy | 4 | Active |
| US11091527B2 | IL-2 muteins and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11965008B2 | IL-2 muteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11779632B2 | IL-2 muteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11091526B2 | IL-2 muteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11466068B2 | Targeted immunotolerance | Chemistry; Metallurgy | 0 | Active |
| US11981715B2 | Tissue targeted immunotolerance with a CD39 effector | Chemistry; Metallurgy | 0 | Active |
| US11945852B2 | IL-2 muteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11739146B2 | MAdCAM targeted immunotolerance | Chemistry; Metallurgy | 0 | Active |
| USRE50550E1 | IL-2 muteins and uses thereof | General | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.